Arcturus Therapeutics Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.About ARCT
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF.
CEOJoseph E. Payne
CEOJoseph E. Payne
Employees176
Employees176
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2013
Founded2013
Employees176
Employees176
ARCT Key Statistics
Market cap175.16M
Market cap175.16M
Price-Earnings ratio-2.50
Price-Earnings ratio-2.50
Dividend yield—
Dividend yield—
Average volume634.65K
Average volume634.65K
High today$6.28
High today$6.28
Low today$6.09
Low today$6.09
Open price$6.14
Open price$6.14
Volume315.11K
Volume315.11K
52 Week high$24.17
52 Week high$24.17
52 Week low$5.85
52 Week low$5.85
Stock Snapshot
Arcturus Therapeutics Holdings(ARCT) stock is priced at $6.17, giving the company a market capitalization of 175.16M. It carries a P/E multiple of -2.50.
During the trading session on 2025-12-30, Arcturus Therapeutics Holdings(ARCT) shares reached a daily high of $6.28 and a low of $6.09. At a current price of $6.17, the stock is +1.2% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 315.11K, compared to an average daily volume of 634.65K.
The stock's 52-week range extends from a low of $5.85 to a high of $24.17.
The stock's 52-week range extends from a low of $5.85 to a high of $24.17.
Analyst ratings
73%
of 11 ratingsBuy
72.7%
Hold
27.3%
Sell
0%
People also own
Based on the portfolios of people who own ARCT. This list is generated using Robinhood data, and it’s not a recommendation.